A detailed history of State Of Alaska, Department Of Revenue transactions in Xencor Inc stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 36,204 shares of XNCR stock, worth $718,649. This represents 0.01% of its overall portfolio holdings.

Number of Shares
36,204
Previous 37,085 2.38%
Holding current value
$718,649
Previous $820,000 16.46%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$18.21 - $24.5 $16,043 - $21,584
-881 Reduced 2.38%
36,204 $685,000
Q1 2024

Apr 19, 2024

SELL
$18.65 - $26.52 $6,825 - $9,706
-366 Reduced 0.98%
37,085 $820,000
Q4 2023

Jan 19, 2024

SELL
$16.53 - $21.42 $4,760 - $6,168
-288 Reduced 0.76%
37,451 $795,000
Q3 2023

Oct 16, 2023

SELL
$20.08 - $25.39 $40,099 - $50,703
-1,997 Reduced 5.03%
37,739 $760,000
Q2 2023

Jul 24, 2023

SELL
$24.77 - $29.9 $32,176 - $38,840
-1,299 Reduced 3.17%
39,736 $992,000
Q1 2023

Apr 17, 2023

SELL
$25.95 - $36.95 $17,931 - $25,532
-691 Reduced 1.66%
41,035 $1.14 Million
Q4 2022

Jan 11, 2023

BUY
$24.79 - $30.86 $9,792 - $12,189
395 Added 0.96%
41,726 $1.09 Million
Q3 2022

Oct 20, 2022

SELL
$24.62 - $32.44 $91,241 - $120,222
-3,706 Reduced 8.23%
41,331 $1.07 Million
Q2 2022

Jul 08, 2022

BUY
$19.74 - $29.01 $85,967 - $126,338
4,355 Added 10.7%
45,037 $1.23 Million
Q1 2022

Apr 14, 2022

SELL
$26.68 - $41.63 $19,343 - $30,181
-725 Reduced 1.75%
40,682 $1.09 Million
Q4 2021

Jan 12, 2022

SELL
$33.67 - $43.44 $38,383 - $49,521
-1,140 Reduced 2.68%
41,407 $1.66 Million
Q3 2021

Oct 07, 2021

BUY
$30.65 - $35.68 $69,054 - $80,387
2,253 Added 5.59%
42,547 $1.39 Million
Q2 2021

Jul 12, 2021

BUY
$34.33 - $44.68 $36,733 - $47,807
1,070 Added 2.73%
40,294 $1.39 Million
Q1 2021

Apr 09, 2021

SELL
$40.81 - $53.88 $224,455 - $296,340
-5,500 Reduced 12.3%
39,224 $1.69 Million
Q4 2020

Jan 08, 2021

SELL
$36.63 - $47.63 $320,219 - $416,381
-8,742 Reduced 16.35%
44,724 $1.95 Million
Q3 2020

Oct 05, 2020

BUY
$30.09 - $43.02 $201,302 - $287,803
6,690 Added 14.3%
53,466 $2.07 Million
Q2 2020

Jul 06, 2020

BUY
$27.76 - $33.42 $27,760 - $33,420
1,000 Added 2.18%
46,776 $1.52 Million
Q1 2020

Apr 06, 2020

BUY
$20.69 - $37.79 $176,278 - $321,970
8,520 Added 22.87%
45,776 $1.37 Million
Q4 2019

Jan 07, 2020

SELL
$32.75 - $41.43 $19,027 - $24,070
-581 Reduced 1.54%
37,256 $1.28 Million
Q3 2019

Oct 02, 2019

BUY
$33.73 - $46.27 $1.28 Million - $1.75 Million
37,837 New
37,837 $1.28 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.19B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.